Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Chaperones and Proteasomes In Neurodegeneration

1 September 2002. Evidence linking certain chaperones and the proteasome to neurodegenerative diseases, such as Huntington’s and Parkinson’s, is growing quickly and therefore was one of topics at last March’s Arthur M. Sackler Colloquium of the National Academy of Sciences, “Self-Perpetuating Structural States in Biology, Disease and Genetics.” The current Early Online PNAS features two reviews arising from this colloquium.

Hideki Sakahira and colleagues from Ulrich Hartl’s lab at the Max Planck Institute for Biochemistry, Martinsried, Germany, review the relationship between toxic polyglutamine (polyQ) expansions and the proteasome machinery. Though all PolyQ-expanded proteins are known to be inherently “sticky” and wont to form fibrillary aggregates, the exact mechanism whereby they damage neurons is still speculative. Sakahira focuses on two proposed models for polyQ toxicity. The sequestration/ transcriptional dysregulation model suggests that protofibrils bind and sequester other essential proteins, such as transcription factors, and in this way disrupt cellular function. The second model predicts that polyQ proteins inhibit the proteasome, the large proteolytic apparatus that chops up proteins marked for removal from the cell. This would cause a backlog of misfolded or denatured protein. Chaperones, so named because they help large and hydrophobic proteins fold correctly, may play a crucial role in both models. They could either prevent PolyQ proteins from sequestering essential transcription factors, or keep them in a soluble form that the proteasome can handle.

Nancy Bonini, University of Pennsylvania, reviews how Drosophila has been instrumental in formulating these models. Chaperones such as the heat shock proteins Hsp70 and Hsp40 can alleviate the effects of polyQ-expanded damage to the fly’s eye. This has been shown in fly models of PolyQ diseases, in which expanded human proteins are expressed in the animal’s neurons. Similarly, these chaperones can alleviate symptoms seen in a Parkinson’s model, in which the mutant a-synuclein found in familial forms of the disease is introduced into the fly.-Tom Fagan.

Reference:Sakahira H, Breuer P, Hayer-Hartl MK, Hartl FU. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proc Natl Acad Sci U S A 2002 Aug 20; (Abstract)

Bonini NM. Chaperoning brain degeneration. Proc Natl Acad Sci U S A 2002 Jul 29; (Abstract)

 
Comments on News and Primary Papers
  Primary Papers: Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.

Comment by:  Eddie Koo, ARF Advisor
Submitted 30 August 2002  |  Permalink Posted 30 August 2002
  I recommend this paper
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad